Results 121 to 130 of about 96,811 (318)

Modelling the impact of atherosclerosis on drug release and distribution from coronary stents [PDF]

, 2015
Although drug-eluting stents (DES) are now widely used for the treatment of coronary heart disease, there remains considerable scope for the development of enhanced designs which address some of the limitations of existing devices.
A Neubert, A Schiavone, A Seidlitz, A Tan, A Tellez, AD Levin, AR Tzafriri, AR Tzafriri, AR Tzafriri, AV Finn, B Semmling, BE Bierer, C Bernelli, C Yang, C. M. McKittrick, C. McCormick, CC O’Brien, CC O’Brien, CJ Creel, CP Naseerali, CW Hwang, CW Hwang, F Bozsak, G Douglas, G Mani, G Nakazawa, G Vairo, GE Ragkousis, GS Getz, H Hara, H Jia, HJ Kuh, HQ Zhao, IB Menown, J Guo, J Watt, J Wiebe, JF Granada, JL Fan, JM Weiler, K Milewski, K. G. Oldroyd, KB Biggs, KR Kamath, LE Perkins, M Kamberi, M Rattazzi, MA Ewart, MA Lovich, MF Prescott, P Coats, P Zunino, R Mongrain, R Virmani, RS Schwartz, RS Schwartz, S Hossainy, S McGinty, S McGinty, S McGinty, S McGinty, S Morlacchi, S Prabhu, S Simsekyilmaz, S. Kennedy, S. McGinty, SK Yazdani, SN Iqbal, T Inoue, T Watanabe, U Baber, VY Hoymans, W Khan, W Khan, W Zhu, WC Carlyle, WJ Denny, X Zhu, Y Nakashima, Y Wang, ZA Ali   +80 more
core   +2 more sources

Is a Drug-Eluting Stent the Default Treatment Strategy for Drug-Eluting Stent Restenosis?∗

Journal of the American College of Cardiology, 2015
In 2001, when Morice et al. [(1)][1] presented the initial results of RAVEL (The Randomized Study With the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions), showing 0% angiographic restenosis 6 months after ...
Colombo, Antonio, Ruparelia, Neil
openaire   +2 more sources

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

British medical journal, 2015
Objective To assess the benefits and risks of short term (12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.
E. Navarese, F. Andreotti, V. Schulze, M. Kołodziejczak, A. Buffon, M. Brouwer, F. Costa, M. Kowalewski, G. Parati, G. Lip, M. Kelm, M. Valgimigli   +11 more
semanticscholar   +1 more source

Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state

Periodontology 2000, EarlyView.
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley   +1 more source

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

Biologics: Targets & Therapy, 2013
Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj  

Development of coronary stents using advanced results of materials science and technology [PDF]

, 2004
Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János, Major, L., Nyitrai, Zs., Puskás, Zs.   +3 more
core  

Everolimus-eluting stents or bypass surgery for multivessel coronary disease [PDF]

, 2015
Copyright © 2015 Massachusetts Medical Society. BACKGROUND: Results of trials and registry studies have shown lower long-term mortality after coronary-artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI) among patients with ...
Bangalore, Sripal, Blecker, Saul, Guo, Yu, Hannan, Edward L., Samadashvili, Zaza, Xu, Jinfeng   +5 more
core   +1 more source

Predictors of 12‐Month MACE Among Diabetic, Prediabetic, and Normoglycemic Patients Undergoing Elective Percutaneous Coronary Intervention: 10 Years' Experience From Tehran Heart Center

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Elevated blood glucose levels in diabetes and prediabetes contribute to vascular inflammation and may increase the risk of major adverse cardiac events (MACE). We sought to evaluate the association between different glycemic statuses and 12‐month MACE in patients undergoing elective percutaneous coronary intervention (PCI ...
Ali Hosseinsabet, Nasrin Etesamifard, Akbar Shafiee, Arash Jalali, Amirhossein Heidari, Nazila Heidari, Hamid Ariannejad, Hassan Aghajani   +7 more
wiley   +1 more source

Research progress of drug eluting balloon in arterial circulatory system

Frontiers in Cardiovascular Medicine
The arterial circulatory system diseases are common in clinical practice, and their treatment options have been of great interest due to their high morbidity and mortality.
Keji Lu, Keji Lu, Xianglin Ye, Xianglin Ye, Yaoxuan Chen, Peng Wang, Meiting Gong, Bing Xuan, Zhaobing Tang, Meiling Li, Jun Hou, Ke Peng, Haifeng Pei, Haifeng Pei   +13 more
doaj   +1 more source

Modelling arterial wall drug concentrations following the insertion of a drug-eluting stent [PDF]

, 2013
A mathematical model of a drug-eluting stent is proposed. The model considers a polymer region, containing the drug initially, and a porous region consisting of smooth muscle cells embedded in an extracellular matrix.
Christopher McCormick, Cook S., Libby P., Lovich M. A., Roger M. Wadsworth, Sean McGinty, Sean McKee   +6 more
core   +1 more source